Ernest Law
Director of Health Economics & Outcomes Research
Ernest is a Director of Health Economics & Outcomes Research on the Global Immunology & Inflammation, Patient & Health Impact team at Pfizer. His research interests include health preferences, patient-reported outcomes, patient-centered and comparative effectiveness research, and shared decision-making. Ernest is involved in conducting early- and late-phase clinical trials, real-world/observational studies, and economic evaluations. He is currently focusing on autoimmune diseases, though his previous role at Pfizer was in breast cancer research and he has presented work in several scientific journals and national and international conferences, including ASCO, ESMO-BC, ESMO, SABCS, ISOQOL, SMDM, and ISPOR. Ernest holds a B.Sc.(Pharm) from the University of Alberta, a Doctor of Pharmacy (PharmD) from the University of British Columbia, and obtained his Ph.D. in Pharmacy (focus Pharmacoeconomics & Outcomes Research) from the University of Illinois at Chicago. He completed a pharmacy practice residency with Alberta Health Services in Canada and a post-doctoral research fellowship with the University of Illinois at Chicago. Ernest is currently based out of the Pfizer Headquarters in New York City.